GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Market Cap

Alzinova AB (OSTO:ALZ) Market Cap : kr51.48 Mil (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Alzinova AB's share price for the quarter that ended in Sep. 2023 was kr2.85. Alzinova AB's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 44.53 Mil. Therefore, Alzinova AB's market cap for the quarter that ended in Sep. 2023 was kr126.91 Mil.

Alzinova AB's quarterly market cap increased from Mar. 2023 (kr102.44 Mil) to Jun. 2023 (kr136.71 Mil) but then declined from Jun. 2023 (kr136.71 Mil) to Sep. 2023 (kr126.91 Mil).

Alzinova AB's annual market cap declined from Dec. 2020 (kr121.47 Mil) to Dec. 2021 (kr101.60 Mil) and declined from Dec. 2021 (kr101.60 Mil) to Dec. 2022 (kr89.80 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alzinova AB's Enterprise Value for Today is kr20.24 Mil.


Alzinova AB Market Cap Historical Data

The historical data trend for Alzinova AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Market Cap Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial 128.19 103.05 121.47 101.60 89.80

Alzinova AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.14 89.80 102.44 136.71 126.91

Competitive Comparison of Alzinova AB's Market Cap

For the Biotechnology subindustry, Alzinova AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzinova AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Alzinova AB's Market Cap falls into.



Alzinova AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Alzinova AB's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=kr2.77*32.419
=kr89.80

Alzinova AB's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=kr2.85*44.5313
=kr126.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB  (OSTO:ALZ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Alzinova AB Market Cap Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzinova AB (OSTO:ALZ) Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines